The priming of antigen‐specific CD4+ and CD8+ T‐cell responses results in the expansion of T helper cells and cytotoxic T lymphocytes, respectively, which infiltrate the tumor sites and destroy tumor cells upon antigen recognition [5, 38]. The gene discussed is CD4; the disease is neoplasm.